€98.70
0.33% today
L&S, Jul 03, 05:15 pm CET
ISIN
US66987V1098
Symbol
NVS
Sector
Industry

Novartis ADR Share price

$106.44
+3.68 3.58% 1M
+5.44 5.39% 6M
+5.47 5.42% YTD
+12.94 13.84% 1Y
+19.37 22.24% 3Y
+19.25 22.08% 5Y
+19.83 22.89% 10Y
NYSE, Closing price Tue, Jul 02 2024
-0.10 0.09%
ISIN
US66987V1098
Symbol
NVS
Sector
Industry

Key metrics

Market capitalization $208.25b
Enterprise Value $225.86b
PER (TTM) P/E ratio 14.35
EV/FCF (TTM) EV/FCF 17.76
EV/Sales (TTM) EV/Sales 4.64
P/S ratio (TTM) P/S ratio 4.28
P/B ratio (TTM) P/B ratio 5.47
Dividend yield 3.51%
Last dividend (FY24) $3.74
Sales growth (TTM) Sales growth -4.53%
Turnover (TTM) Turnover $48.66b
EBIT (operating result TTM) EBIT $13.33b
Free cash flow (TTM) Free cash flow $12.72b
Cash position $9.75b
EPS (TTM) EPS $7.42
P/E ratio expected 20.26
P/S ratio expected 4.21
EV/Sales expected 4.57
Short interest 0.26%
Show more

Is Novartis ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,952 stocks worldwide.

Novartis ADR Share analysis

Unlock Scores for Free

Analyst opinions

28 Analysts have issued a Novartis ADR forecast:

10x Buy
36%
16x Hold
57%
2x Sell
7%

Analyst opinions

28 Analysts have issued a Novartis ADR forecast:

Buy
36%
Hold
57%
Sell
7%

Financial data from Novartis ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '24
+/-
%
11,829 11,829
9% 9%
100%
- Direct costs 3,130 3,130
23% 23%
26%
8,699 8,699
2% 2%
74%
- Selling and administrative expenses 1,526 1,526
7% 7%
13%
- Research and development costs 2,230 2,230
3% 3%
19%
4,943 4,943
7% 7%
42%
- Depreciation and amortization 1,314 1,314
34% 34%
11%
EBIT (operating result) EBIT 3,629 3,629
10% 10%
31%
Net profit 2,688 2,688
17% 17%
23%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Novartis ADR share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Novartis ADR Share News

Positive
Seeking Alpha
4 days ago
The market remains near record highs with the best-ever presidential election year return and 13th-best S&P return through the first half of the year. Free cash flow yield is the best valuation metric since 1990, averaging 17.6% annual returns for the most undervalued companies over the last 33 years. Screening for high free cash flow yield dividend aristocrats can provide a diversified portfol...
Positive
Seeking Alpha
11 days ago
Stocks have been on fire since October lows, with many investors worried about bubbles and looming corrections. Even with the market at an all-time high, there are always extraordinary blue-chip bargains to buy. Optimal portfolio design with 11 sector Ultra SWAN blue-chip max volatility-adjusted return potential can provide good returns and lower volatility in bear markets.
Positive
InvestorPlace
16 days ago
Biotech stocks operate under a core ethos. While there's been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals – when you think about it, nothing is more valuable than one's health.
More Novartis ADR News

Company profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Vasant Narasimhan
Employees 76,057
Founded 1996
Website www.novartis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today